Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comboprofen for DOMS
NCT03223519Phase 2Completed
- Sponsor
- Spherium Biomed
- Start
- Jul 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of comboprofen in delayed onset muscle soreness (DOMS), sponsored by Spherium Biomed. Started Jul 2017; status: completed.
02
Drugs
comboprofen
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT03223519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03223519.